| SpectraBase Spectrum ID |
5ZGqXwWzySm |
| Name |
1-(2-Dibenzylaminoethyl)-4-benzylpiperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
399.267448075 u |
| Formula |
C27H33N3 |
| InChI |
InChI=1S/C27H33N3/c1-4-10-25(11-5-1)22-29-19-16-28(17-20-29)18-21-30(23-26-12-6-2-7-13-26)24-27-14-8-3-9-15-27/h1-15H,16-24H2 |
| InChIKey |
WDRLNVTWUFDGHE-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
399.582 g/mol |
| Nominal Mass |
399 u |
| Quality |
994 |
| Retention Index |
3119 |
| SMILES |
C(N(CC1=CC=CC=C1)CCN1CCN(CC=2C=CC=CC2)CC1)C=1C=CC=CC1 |
| SPLASH |
splash10-01ox-9471000000-c88bf7ab6230f933e15a |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(2-dibenzylaminoethyl)-4-benzyl
N,N-dibenzyl-2-(4-benzylpiperazin-1-yl)ethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_010978 |
